NasdaqCM - Delayed Quote USD
Gyre Therapeutics, Inc. (GYRE)
9.00
+0.50
+(5.88%)
At close: June 10 at 4:00:01 PM EDT
Insider Purchases Last 6 Months
| Shares | Transactions | |
|---|---|---|
| Purchases | 715,000 | 3 |
| Sales | 136,383 | 38 |
| Net Shares Purchased (Sold) | 578,617 | 41 |
| Total Insider Shares Held | 80.39M | -- |
| % Net Shares Purchased (Sold) | 0.70% | -- |
Net Institutional Purchases Prior Quarter to Latest Quarter
| Shares | |
|---|---|
| Net Shares Purchased (Sold) | -- |
| % Change in Institutional Shares Held | -- |
Insider Transactions Reported - Last Two Years
| Insider | Transaction | Type | Value | Date |
|---|---|---|---|---|
| MA SONGJIANG President | Sale at price 10.07 - 10.28 per share. | Indirect | 26,179 | May 28, 2025 |
| MA SONGJIANG President | Sale at price 10.24 - 10.97 per share. | Indirect | 23,804 | May 23, 2025 |
| MA SONGJIANG President | Sale at price 10.83 - 11.25 per share. | Indirect | 44,160 | May 21, 2025 |
| MA SONGJIANG President | Sale at price 11.11 - 11.31 per share. | Indirect | 44,840 | May 19, 2025 |
| MA SONGJIANG President | Sale at price 10.68 - 11.30 per share. | Indirect | 21,586 | May 15, 2025 |
| MA SONGJIANG President | Sale at price 10.56 - 11.37 per share. | Indirect | 43,860 | May 13, 2025 |
| EASTLING THOMAS WILSON Director | Conversion of Exercise of derivative security at price 6.93 per share. | Direct | 103,950 | Apr 16, 2025 |
| YE WEIGUO Chief Operating Officer | Conversion of Exercise of derivative security at price 0.75 per share. | Direct | 37,500 | Apr 1, 2025 |
| YE WEIGUO Chief Operating Officer | Conversion of Exercise of derivative security at price 0.75 per share. | Direct | 487,500 | Mar 27, 2025 |
| MA SONGJIANG President | Sale at price 10.00 per share. | Indirect | 1,740 | Mar 21, 2025 |
| MA SONGJIANG President | Sale at price 10.09 - 10.13 per share. | Indirect | 40,440 | Mar 20, 2025 |
| MA SONGJIANG President | Sale at price 10.24 - 12.09 per share. | Indirect | 26,658 | Mar 18, 2025 |
| MA SONGJIANG President | Sale at price 11.80 - 12.31 per share. | Indirect | 48,220 | Mar 14, 2025 |
| MA SONGJIANG President | Sale at price 11.40 - 11.74 per share. | Indirect | 46,280 | Mar 12, 2025 |
| MA SONGJIANG President | Sale at price 10.13 - 12.14 per share. | Indirect | 40,632 | Mar 10, 2025 |
| MA SONGJIANG President | Sale at price 10.80 - 10.98 per share. | Indirect | 43,560 | Mar 6, 2025 |
| MA SONGJIANG President | Sale at price 10.86 - 11.23 per share. | Indirect | 44,180 | Mar 4, 2025 |
| MA SONGJIANG President | Sale at price 11.33 - 11.41 per share. | Indirect | 45,480 | Feb 28, 2025 |
| MA SONGJIANG President | Sale at price 11.37 - 11.63 per share. | Indirect | 46,000 | Feb 26, 2025 |
| MA SONGJIANG President | Sale at price 10.60 - 12.60 per share. | Indirect | 45,190 | Feb 24, 2025 |
| MA SONGJIANG President | Sale at price 12.29 - 12.40 per share. | Indirect | 49,380 | Feb 20, 2025 |
| MA SONGJIANG President | Sale at price 11.94 - 12.49 per share. | Indirect | 48,860 | Feb 18, 2025 |
| MA SONGJIANG President | Sale at price 11.49 - 11.69 per share. | Indirect | 46,360 | Feb 13, 2025 |
| MA SONGJIANG President | Sale at price 11.52 - 11.90 per share. | Indirect | 45,435 | Feb 11, 2025 |
| MA SONGJIANG President | Sale at price 12.16 - 12.85 per share. | Indirect | 50,020 | Feb 7, 2025 |
| MA SONGJIANG President | Sale at price 11.62 - 12.84 per share. | Indirect | 48,029 | Feb 5, 2025 |
| MA SONGJIANG President | Sale at price 11.47 - 11.51 per share. | Indirect | 45,960 | Feb 3, 2025 |
| MA SONGJIANG President | Sale at price 11.37 - 11.43 per share. | Indirect | 45,600 | Jan 30, 2025 |
| MA SONGJIANG President | Sale at price 11.18 - 11.51 per share. | Indirect | 45,380 | Jan 28, 2025 |
| MA SONGJIANG President | Sale at price 10.49 - 10.89 per share. | Indirect | 42,760 | Jan 24, 2025 |
| MA SONGJIANG President | Sale at price 10.63 - 10.85 per share. | Indirect | 42,960 | Jan 22, 2025 |
| MA SONGJIANG President | Sale at price 10.71 - 10.72 per share. | Indirect | 42,860 | Jan 17, 2025 |
| MA SONGJIANG President | Sale at price 10.39 - 10.85 per share. | Indirect | 42,480 | Jan 15, 2025 |
| MA SONGJIANG President | Sale at price 10.02 - 10.10 per share. | Indirect | 11,157 | Jan 13, 2025 |
| MA SONGJIANG President | Sale at price 10.02 - 10.16 per share. | Indirect | 22,336 | Jan 7, 2025 |
| MA SONGJIANG President | Sale at price 11.03 - 12.40 per share. | Indirect | 47,543 | Jan 3, 2025 |
| MA SONGJIANG President | Sale at price 12.30 - 12.50 per share. | Indirect | 49,600 | Dec 31, 2024 |
| MA SONGJIANG President | Sale at price 12.58 - 13.05 per share. | Indirect | 50,553 | Dec 27, 2024 |
| MA SONGJIANG President | Sale at price 11.93 - 12.44 per share. | Indirect | 48,399 | Dec 24, 2024 |
| MA SONGJIANG President | Sale at price 10.82 - 10.90 per share. | Indirect | 43,440 | Dec 20, 2024 |
| MA SONGJIANG President | Sale at price 10.94 - 12.11 per share. | Indirect | 44,852 | Dec 18, 2024 |
| USMAN NASSIM Director | Sale at price 12.00 per share. | Direct | 41,438 | Jun 28, 2024 |
| USMAN NASSIM Director | Conversion of Exercise of derivative security at price 6.93 per share. | Direct | 23,922 | Jun 28, 2024 |
| USMAN NASSIM Director | Sale at price 13.86 - 15.63 per share. | Direct | 282,577 | May 1, 2024 |
| USMAN NASSIM Director | Conversion of Exercise of derivative security at price 6.93 per share. | Direct | 138,600 | May 1, 2024 |
| USMAN NASSIM Director | Sale at price 16.15 per share. | Direct | 323,000 | Apr 1, 2024 |
| USMAN NASSIM Director | Conversion of Exercise of derivative security at price 6.93 per share. | Direct | 138,600 | Apr 1, 2024 |
| USMAN NASSIM Director | Sale at price 17.26 per share. | Direct | 345,200 | Mar 15, 2024 |
| USMAN NASSIM Director | Conversion of Exercise of derivative security at price 6.93 per share. | Direct | 138,600 | Mar 15, 2024 |
Related Tickers
2160.T GNI Group Ltd.
3,770.00
+3.43%
TSBX Turnstone Biologics Corp.
0.3629
-1.39%
ATXS Astria Therapeutics, Inc.
5.71
-1.38%
ATXI Avenue Therapeutics, Inc.
0.2642
+31.61%
4974.T Takara Bio Inc.
801.00
+0.50%
4565.T Nxera Pharma Co., Ltd.
942.00
-0.74%
RB0.SG Regenxbio Inc
8.45
+0.60%
OLMA Olema Pharmaceuticals, Inc.
4.2100
-3.88%
LENZ LENZ Therapeutics, Inc.
28.08
-10.06%
EMMA Emmaus Life Sciences, Inc.
0.0164
0.00%